On March 20, 2024, Nanalysis Scientific Corp., closed the transaction. The company announced that it has issued 2,222,222 units at an issue price of CAD 0.45 per unit for the gross proceeds of CAD 999,999.9. A total of 8,888,888 Units were issued pursuant to the Offering and 2,222,222 Units were issued pursuant to the Concurrent Offering. Each Unit will consist of one common share of the Company and one half of one common share purchase warrant of the Company. Each Warrant will be exercisable at CAD 0.65 for a period of 24 months following the closing date of the Offering. In connection with the Offering, the agents received a cash commission equal to 7.0% of the gross proceeds, with a reduced commission applied to sales made to members of the president's list of 3.5%. Additionally, the agents were granted broker warrants in an amount equal to 8.0% of the total number of Units issued under the Offering and Concurrent Offering, subject to reduction for president's list sales of 4.0%. Each Broker Warrant is exercisable into one Common Share at a price of CAD 0.65 for a period of 24 months following closing. Such cash commission totaled CAD 335,541.47 and such Broker Warrants totaled 852,169. The Broker Warrants are subject to a 4-month hold period. The company paid CAD 69,999.993 as agent fees.

The TSX Venture Exchange has accepted for filing documentation with respect to a brokered private placement. The transaction included participation from 63 placees including existing insider involvement of 2 insiders for 80,000 and pro group involvement of 5 insiders for 832,640.